~~<i id='9ACBF21FFC'><strike id='9ACBF21FFC'><tt id='9ACBF21FFC'><pre id='9ACBF21FFC'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

knowledge

entertainment

author：Wikipedia 2025-09-27 12:57:08 - browse：992

Sarepta Therapeutics said Monday afternoon that its gene therapy for Duchenne muscular dystrophy failed to improve muscle function compared to a placebo in a large clinical trial — likely a major disappointment for patients and doctors who have been desperately awaiting the treatment for years.

The company said all patients in the study improved and that secondary measurements indicated the drug was having an effect. Nevertheless, the results are likely to raise questions about whether the Food and Drug Administration will expand access to the medicine.

Trading in Sarepta shares was halted at $107 with the release of the study results.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： People with substance use disorder deserve online privacy

focus

Wikipedia

knowledge

hotspot

entertainment

UCSanDiegostudentsprotestedatanalumnieventinMay,wheretheyaccuseduniversityleadershipofwagetheft.Cour

WSS

The unintended consequences of overturning Roe v. Wade

What happened to the House vote on health price transparency?

Transgender sports debate: Physicians say bans are health issue

Midwives could help bridge maternal health disparities in the U.S.

Ozempic cut risk of death in diabetes patients with chronic kidney disease

Ozempic cut risk of death in diabetes patients with chronic kidney disease

knowledge

entertainment

focus

New air purifier tech could be key to improving indoor air quality

Lawsuit challenges CMS nursing home minimum staffing rule

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

White House Covid adviser calls on docs to combat misinformation

New air purifier tech could be key to improving indoor air quality

How the messy conversation about Dolly changed bioethics

Heart attack and stroke risk calculators need revising

Should insurance cover cosmetic surgery?

Medicare proposal to cover medical devices draws a mixed reaction

Patients, doctors press FTC to beef up hospital merger scrutiny

Wikipedia

Clinicians often fail to acknowledge the pain caused by long Covid

Achieving telehealth equity for people with hearing loss

New research sheds light on how often breast cancer is overdiagnosed

White House Covid adviser calls on docs to combat misinformation

Medical students need to learn the potent medicine of empathy

White House Covid adviser calls on docs to combat misinformation

knowledge

knowledge

hotspot

entertainment